Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (41-50 of 258) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 7, 2013
Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patientsArwen Stikvoort, Jens Gertow, Mikael Sundin, et al.
Transplantation and Cellular Therapy|June 26, 2026
International Survey and NGS-Based Indel Chimerism Detection of HLA Loss in Relapsed Haploidentical andMismatched Unrelated Donor Transplant RecipientsNihar Desai, Linnea Pettersson, Jinguo Wang, et al.
Transplant Immunology|June 30, 2011
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantationAnna Nordlander, Michael Uhlin, Olle Ringdén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantationMats Remberger, Emma Watz, Olle Ringdén, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 26, 2013
Hospital care or home care after allogeneic hematopoietic stem cell transplantation--patients' experiences of care and supportKarin Bergkvist, Joacim Larsen, Unn-Britt Johansson, et al.
International Journal of Hematology|May 22, 2023
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapyEshrak Al-Shaibani, Igor Novitzky-Basso, Jonas Mattsson, et al.
European Journal of Haematology|December 17, 2009
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplantsRichard Olsson, Mats Remberger, Zuzana Hassan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell TransplantationOla Blennow, Mats Remberger, Johan Törlén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2014
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains highOla Blennow, Gustav Fjaertoft, Jacek Winiarski, et al.
Transplantation|October 14, 2004
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantationKatarina Le Blanc, Mats Remberger, Mehmet Uzunel, et al.
Pageof 26

Showing results (41-50 of 258) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 7, 2013
Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patientsArwen Stikvoort, Jens Gertow, Mikael Sundin, et al.
Transplantation and Cellular Therapy|June 26, 2026
International Survey and NGS-Based Indel Chimerism Detection of HLA Loss in Relapsed Haploidentical andMismatched Unrelated Donor Transplant RecipientsNihar Desai, Linnea Pettersson, Jinguo Wang, et al.
Transplant Immunology|June 30, 2011
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantationAnna Nordlander, Michael Uhlin, Olle Ringdén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantationMats Remberger, Emma Watz, Olle Ringdén, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 26, 2013
Hospital care or home care after allogeneic hematopoietic stem cell transplantation--patients' experiences of care and supportKarin Bergkvist, Joacim Larsen, Unn-Britt Johansson, et al.
International Journal of Hematology|May 22, 2023
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapyEshrak Al-Shaibani, Igor Novitzky-Basso, Jonas Mattsson, et al.
European Journal of Haematology|December 17, 2009
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplantsRichard Olsson, Mats Remberger, Zuzana Hassan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell TransplantationOla Blennow, Mats Remberger, Johan Törlén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2014
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains highOla Blennow, Gustav Fjaertoft, Jacek Winiarski, et al.
Transplantation|October 14, 2004
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantationKatarina Le Blanc, Mats Remberger, Mehmet Uzunel, et al.
Pageof 26